Rob C Andrews
Overview
Explore the profile of Rob C Andrews including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dirks M, Jameson T, Andrews R, Dunlop M, Abdelrahman D, Murton A, et al.
Am J Physiol Endocrinol Metab
. 2024 Jan;
326(3):E277-E289.
PMID: 38231001
Although the mechanisms underpinning short-term muscle disuse atrophy and associated insulin resistance remain to be elucidated, perturbed lipid metabolism might be involved. Our aim was to determine the impact of...
2.
Dirks M, Jameson T, Andrews R, Dunlop M, Abdelrahman D, Murton A, et al.
bioRxiv
. 2023 Oct;
PMID: 37873346
The mechanisms underpinning short-term muscle disuse atrophy remain to be elucidated, but perturbations in lipid metabolism may be involved. Specifically, positive muscle non-esterified fatty acid (NEFA) balance has been implicated...
3.
Nakanga W, Crampin A, Mkandawire J, Banda L, Andrews R, Hattersley A, et al.
PLOS Glob Public Health
. 2023 Sep;
3(9):e0001263.
PMID: 37756263
Sub-Saharan Africa is projected to have the highest increase in the number of people with diabetes worldwide. However, the drivers of diabetes in this region have not been clearly elucidated....
4.
Bowman P, Patel K, McDonald T, Holst J, Hartmann B, Leveridge M, et al.
J Diabetes Investig
. 2023 Aug;
14(12):1378-1382.
PMID: 37602910
The incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), are thought to be the main drivers of insulin secretion in individuals with sulfonylurea (SU)-treated KCNJ11 permanent neonatal diabetes....
5.
Morris A, Bright C, Cocks M, Gibson N, Goff L, Greaves C, et al.
Diabet Med
. 2023 Jun;
40(9):e15169.
PMID: 37381170
Aims: To describe the process and outputs of a workshop convened to identify key priorities for future research in the area of diabetes and physical activity and provide recommendations to...
6.
Scott S, Hayes C, Zeuger T, Davies A, Andrews R, Cocks M
Diabetes Spectr
. 2023 May;
36(2):114-126.
PMID: 37193206
This article provides practical tips for advising people with type 2 diabetes on how to engage in regular exercise safely and effectively. Its focus is on individuals who wish to...
7.
Nakanga W, Balungi P, Niwaha A, Shields B, Hughes P, Andrews R, et al.
PLoS One
. 2022 Feb;
17(2):e0264432.
PMID: 35226681
Introduction: Sodium fluoride (NaF) tubes are the recommended tubes for glucose measurements, but these are expensive, have limited number of uses, and are not always available in low resource settings....
8.
Rodgers L, Hill A, Dennis J, Craig Z, May B, Hattersley A, et al.
BMC Med
. 2021 Aug;
19(1):184.
PMID: 34412655
Background: Type 2 diabetes (T2D) is common and increasing in prevalence. It is possible to prevent or delay T2D using lifestyle intervention programmes. Entry to these programmes is usually determined...
9.
Scott S, Shepherd S, Andrews R, Narendran P, Purewal T, Kinnafick F, et al.
Diabetes Care
. 2019 Sep;
42(12):2330-2333.
PMID: 31530660
Objective: Adopt a multidisciplinary approach to evaluate a virtually supervised home-based high-intensity interval training (Home-HIT) intervention in people with type 1 diabetes. Research Design And Methods: Eleven individuals with type...
10.
Litchfield I, Andrews R, Narendran P, Greenfield S
Front Endocrinol (Lausanne)
. 2019 Mar;
10:76.
PMID: 30837947
One way of improving the prognosis for the growing numbers of people with type 1 diabetes (T1D) is to increase their frequency of exercise. One known barrier to this is...